Home

JPMorgan Chase & Co (JPM)

239.01
0.00 (0.00%)

JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments

The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close239.01
Open-
Bid238.04
Ask238.81
Day's RangeN/A - N/A
52 Week Range179.20 - 280.25
Volume1,884
Market Cap736.72B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield5.000 (2.09%)
1 Month Average Volume11,631,082

News & Press Releases

The History of J.P. Morgan: From Humble Beginnings to Global Titan
J.P. Morgan, officially known today as JPMorgan Chase & Co. (NYSE:JPM), stands as one of the most influential financial institutions in the world. Its history spans over two centuries, weaving together tales of ambition, innovation, economic crises, and strategic mergers. From its origins as a modest merchant bank to
Via MarketMinute · March 20, 2025
Is Tariff An Issue For Restaurant Sector? J.P. Morgan Highlights Winners & Losersbenzinga.com
J.P. Morgan analyst John Ivankoe hosted Bloomin' Brands, CAVA Group and others at the Las Vegas forum. A major takeaway: focus on "doing fewer things better" with continued investments in customer and employee experiences. The analyst recommends adding fresh investments in BROS, SBUX, and CAVA, while maintaining cautious optimism on CMG and EAT.
Via Benzinga · March 20, 2025
JPMorgan: Spire Positioned For Growth With Favorable Missouri Legislation, Rate Case Developmentsbenzinga.com
JPMorgan upgrades Spire Inc. to Overweight, raises price forecast to $85. Analyst cites regulatory improvements in Missouri and positive factors for increased earnings and growth potential.
Via Benzinga · March 20, 2025
Holley May Bear The Brunt Of Ongoing Macroeconomic Challenges, Analyst Highlights Softer Top-line Outlookbenzinga.com
JP Morgan analyst maintains Neutral rating on Holley, citing macroeconomic challenges and a softer revenue outlook despite strong EBITDA guidance.
Via Benzinga · March 20, 2025
JPMorgan Backs CAVA's Expansion Potential As Yum! Brands Plans Major Taco Bell, KFC Growthbenzinga.com
JPMorgan sees potential in restaurant stocks despite dip in consumer confidence data. Ivankoe upgrades CAVA Group, maintains neutral rating for Yum!
Via Benzinga · March 20, 2025
Five Below Posts Q4 Earnings Beat: FY25 Guidance Reflects Tariff Headwinds, Analysts Saybenzinga.com
FIVE stock up on Q4 earnings beat amid exciting earnings season. JPMorgan rates Underweight, Goldman Sachs rates Buy.
Via Benzinga · March 20, 2025
JPMorgan Chase & Co. Stock Update: A Steady Rise Amid New ETN Launch
As of this morning, March 20, 2025, JPMorgan Chase & Co. (NYSE: JPM) is experiencing a modest uptick in its stock price. At 10:20:24 AM EDT, the stock is trading at $240.10, reflecting a gain of $0.99, or 0.41%, from its previous close of $239.11.
Via MarketMinute · March 20, 2025
Apex Group Announces Key Leadership Appointment to Accelerate Global Growth
New York, New York--(Newsfile Corp. - March 20, 2025) - Apex Group Ltd. ("the Group"), the leading global financial services...
Via Newsfile · March 20, 2025
Is Nvidia Sitting On The AI Goldmine No One Sees Yet?benzinga.com
JPMorgan analyst sees Nvidia dominating in AI and potentially outgrowing data center spending with next-gen chips and potential AI factory investments.
Via Benzinga · March 20, 2025
Wall Street Remains Mixed On XPeng Stock Despite Positive Q4 – But Retails Stays Confidentstocktwits.com
While Barclays raised XPeng’s price target to $20 from $7, JPMorgan lowered its target from $35 to $31.
Via Stocktwits · March 20, 2025
JPMorgan Chase Financial Company LLC Launches Inverse VIX® Short-Term Futures ETNs (NYSE Arca: VYLD)
JPMorgan Chase Financial Company LLC (“JPMorgan Financial”) announced that today is the first day of trading on NYSE Arca for its Inverse VIX® Short-Term Futures ETNs due March 22, 2045 under the ticker symbol “VYLD” (the “ETNs”). Any payment on the ETNs is fully and unconditionally guaranteed by JPMorgan Chase & Co. (“JPMorgan Chase” or the “Firm”).
By JPMorgan Chase & Co. · Via Business Wire · March 20, 2025
SAP Analyst Says German Software Giant’s Stock Presents ‘Attractive Buying Opportunity:’ Retail’s Upbeatstocktwits.com
JPMorgan analysts said SAP stock was “overly dragged down” by a number of “idiosyncratic” factors that impacted the U.S. software sector.
Via Stocktwits · March 20, 2025
Jamie Dimon Says 'There's A Lot Of Turbulence Out There' Amid Trump Tariffs, Inflation Woes And Geopolitical Risksbenzinga.com
Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE: JPM), expressed his views on the current economic landscape, highlighting concerns over geopolitical tensions and potential tariff impacts.
Via Benzinga · March 20, 2025
International Paper Gets ‘Overweight’ Rating At JPMorgan, New CEO Appointment Seen As A Positive: Retail’s Not Sure Yetstocktwits.com
This comes ahead of the company’s investor day scheduled for March 25, where new CEO Andy Silvernail is set to field questions about the company’s strategies going forward.
Via Stocktwits · March 20, 2025
Retail Traders Turn Bullish On Etsy Following Analyst Move Amid Macro Challengesstocktwits.com
JPMorgan analyst Bryan Smilek assigned a ‘Neutral’ rating with a $50 price target.
Via Stocktwits · March 19, 2025
Crypto Mixed Post Trump-Putin Call; Trump Eyes HIV Program Cuts, Gilead Dips; Nvidia's AI Lead Secure Through 2028, Says JPMorgan – Top Headlines While The U.S. Sleptbenzinga.com
Via Benzinga · March 19, 2025
Nvidia Extends AI Reign To 2028: JPMorgan Says It's Still '1-2 Steps Ahead'benzinga.com
Nvidia Corp is dominating the AI acceleration market, with a roadmap stretching to 2028 and impressive new products like Blackwell Ultra and Rubin.
Via Benzinga · March 19, 2025
Adobe's AI-Fueled Growth Could Power A 38% Upside - Here's Why JPMorgan Is Bullishbenzinga.com
Adobe Inc is showing strong AI-driven growth with $3.5 billion in annual recurring revenue and plans to double AI-first products, making it an attractive stock for investors.
Via Benzinga · March 19, 2025
Nvidia Stock Climbs Pre-Market After Jensen Huang’s GTC 2025 Keynote – Wall Street, Retail Bullish On AI Roadmapstocktwits.com
Bank of America (BofA) said Nvidia is “deepening its competitive moat,” while JPMorgan noted that the company’s “aggressive roadmap” keeps it “1-2 steps ahead of its competitors.”
Via Stocktwits · March 19, 2025
Kamilla Pinel Unveils the DREAM Framework to Redefine Success for High Achievers
Leadership coach Kamilla Pinel introduces a transformative approach to success through her proprietary DREAM Framework, helping high achievers align ambition with fulfillment.
JPMorganChase Declares Common Stock Dividend
JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.
By JPMorgan Chase & Co. · Via Business Wire · March 18, 2025
The Uncertainty-Fueled Market Correctionfool.com
Companies, investors, and countries are all having a hard time knowing what the future holds. And that makes forecasting hard.
Via The Motley Fool · March 18, 2025
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentalsbenzinga.com
JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management's outlook for recovery and growth in 2025-2027.
Via Benzinga · March 18, 2025
JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovrebenzinga.com
JP Morgan sees steady growth for Apellis' Syfovre, lowering the price target to $45. Syfovre sales hit $167.8M in Q4, with over 94,000 doses delivered.
Via Benzinga · March 18, 2025
10 Financials Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · March 18, 2025